Bill Text: IL SB0670 | 2011-2012 | 97th General Assembly | Amended
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Abused and Neglected Long Term Care Facility Residents Reporting Act. Makes a technical change in a Section concerning duties of the Department of Public Health.
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: (Passed) 2011-08-19 - Public Act . . . . . . . . . 97-0456 [SB0670 Detail]
Download: Illinois-2011-SB0670-Amended.html
Bill Title: Amends the Abused and Neglected Long Term Care Facility Residents Reporting Act. Makes a technical change in a Section concerning duties of the Department of Public Health.
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: (Passed) 2011-08-19 - Public Act . . . . . . . . . 97-0456 [SB0670 Detail]
Download: Illinois-2011-SB0670-Amended.html
| |||||||
| |||||||
| |||||||
1 | AMENDMENT TO SENATE BILL 670
| ||||||
2 | AMENDMENT NO. ______. Amend Senate Bill 670 by replacing | ||||||
3 | everything after the enacting clause with the following:
| ||||||
4 | "Section 5. The Pharmacy Practice Act is amended by | ||||||
5 | changing Section 26 as follows:
| ||||||
6 | (225 ILCS 85/26) | ||||||
7 | (Section scheduled to be repealed on January 1, 2018) | ||||||
8 | Sec. 26. Anti-epileptic drug product selection prohibited. | ||||||
9 | (a) The General Assembly finds that this Section is | ||||||
10 | necessary for the immediate preservation of the public peace, | ||||||
11 | health, and safety. | ||||||
12 | (b) In this Section: | ||||||
13 | "Anti-epileptic drug " means (i) any drug prescribed for the | ||||||
14 | treatment of epilepsy or (ii) a drug used to treat or prevent | ||||||
15 | seizures. | ||||||
16 | "Epilepsy" means a neurological condition characterized by |
| |||||||
| |||||||
1 | recurrent seizures. | ||||||
2 | "Seizure" means a brief disturbance in the electrical | ||||||
3 | activity of the brain. | ||||||
4 | (c) When the prescribing physician has indicated on the | ||||||
5 | original prescription "may not substitute", a pharmacist may | ||||||
6 | not interchange an anti-epileptic drug or formulation of an | ||||||
7 | anti-epileptic drug for the treatment of epilepsy without | ||||||
8 | notification and the documented consent of the prescribing | ||||||
9 | physician and the patient or the patient's parent, legal | ||||||
10 | guardian, or spouse.
This Section does not apply to medication | ||||||
11 | orders issued for anti-epileptic drugs for any in-patient care | ||||||
12 | in a licensed hospital.
| ||||||
13 | (d) If a pharmacist substitutes any generic prescription in | ||||||
14 | place of a brand-name anti-epileptic drug, then the pharmacist | ||||||
15 | shall provide written notice to the patient no later than the | ||||||
16 | time the prescription is dispensed. | ||||||
17 | (Source: P.A. 94-936, eff. 6-26-06; 95-689, eff. 10-29-07.)".
|